LEADER 02022oam  2200493Ia 450 
001 9910697499703321
005 20080821092457.0
035   $a(CKB)5470000002387940
035   $a(OCoLC)86079094
035   $a(EXLCZ)995470000002387940
100   $a20070320d2006      ua             0
101 0 $aeng
135   $au|cn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aHuman use pharmaceuticals in the estuarine environment$b[electronic resource] $ea survey of the Chesapeake Bay, Biscayne Bay and Gulf of the Farallones /$fAnthony S. Pait ... [and others]
210  1$aSilver Spring, Md. :$cU.S. Dept. of Commerce, National Oceanic and Atmospheric Administration, National Ocean Service, National Centers for Coastal Ocean Science, Center for Coastal Monitoring and Assessment,$d[2006]
215   $aiv, 21 pages $cdigital, PDF file
225 1 $aNOAA technical memorandum NOS NCCOS ;$v7
300   $aTitle from title screen (viewed on Mar. 16, 2007).
300   $a"August 2006."
320   $aIncludes bibliographical references (pages 20-21).
517   $aHuman use pharmaceuticals in the estuarine environment 
606   $aEstuarine ecology$zChesapeake Bay (Md. and Va.)
606   $aEstuarine ecology$zFlorida$zBiscayne Bay
606   $aEstuarine ecology$zCalifornia$zFarallones, Gulf of the
606   $aEstuarine ecology$xEffect of drugs on$xResearch
606   $aDrugs$xMeasurement$vObservations
615  0$aEstuarine ecology
615  0$aEstuarine ecology
615  0$aEstuarine ecology
615  0$aEstuarine ecology$xEffect of drugs on$xResearch.
615  0$aDrugs$xMeasurement
701   $aPait$b Anthony S$01403329
712 02$aCenter for Coastal Monitoring and Assessment (U.S.)
801  0$bOLA
801  1$bOLA
801  2$bOLA
801  2$bGPO
906   $aBOOK
912   $a9910697499703321
996   $aHuman use pharmaceuticals in the estuarine environment$93511092
997   $aUNINA